BridgeBio Pharma (BBIO) stock Forecast for 2022 – 2026

BridgeBio Pharma (BBIO) stock Forecast for 2022 – 2026

Last update: March 23, 2023 (10:15)

Sector: Healthcare

The share price of BridgeBio Pharma, Inc. (BBIO) now

What analysts predict: $25.67
52-week High/Low: $19.95 / $4.98

50/200 Day Moving Average: $11.17 / $10.02

This figure corresponds to the Average Price over the previous 50/200 days. For BridgeBio Pharma stocks, the 50-day moving average is the support level today.

For BridgeBio Pharma stocks, the 200-day moving average is the support level today.

Are you interested in BridgeBio Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the BridgeBio Pharma stock price in 2023, 2024, 2025, 2026, 2027. How much will one BridgeBio Pharma share be worth in 2023 - 2027?

When should I take profit in BridgeBio Pharma stock? When should I record a loss on BridgeBio Pharma stock? What are analysts' forecasts for BridgeBio Pharma stock? What is the future of BridgeBio Pharma stock? We forecast BridgeBio Pharma stock performance using neural networks based on historical data on BridgeBio Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

BridgeBio Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for BridgeBio Pharma shares. This happens once a day.




Historical and forecast chart of BridgeBio Pharma stock

The chart below shows the historical price of BridgeBio Pharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the BridgeBio Pharma stock price can be found in the table below.

Long-term forecasts by years.

BridgeBio Pharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Mar 25 12.88 12.67 13.26 4.66
Mar 26 12.76 12.44 12.98 4.36
Mar 27 12.45 12.12 12.63 4.18
Mar 28 12.32 12.08 12.61 4.41
Mar 29 12.65 12.44 13.00 4.52
Mar 30 13.09 12.76 13.40 5.05
Mar 31 12.91 12.70 13.21 4.03
Apr 01 12.97 12.66 13.20 4.24
Apr 02 13.32 13.16 13.64 3.63
Apr 03 12.96 12.64 13.28 5.09
Apr 04 12.51 12.20 12.62 3.49
Apr 05 12.74 12.53 13.01 3.80
Apr 06 13.02 12.72 13.14 3.30
Apr 07 13.09 12.96 13.37 3.18
Apr 08 12.98 12.88 13.09 1.60
Apr 09 13.26 12.92 13.42 3.84
Apr 10 13.28 12.93 13.55 4.75
Apr 11 13.61 13.22 13.89 5.10
Apr 12 13.28 13.14 13.59 3.44
Apr 13 13.18 13.07 13.50 3.24
Apr 14 12.95 12.58 13.33 5.90
Apr 15 13.00 12.71 13.17 3.67
Apr 16 12.82 12.66 13.02 2.85
Apr 17 12.70 12.48 12.92 3.50
Apr 18 12.49 12.38 12.78 3.29
Apr 19 12.38 12.15 12.48 2.71
Apr 20 12.50 12.22 12.82 4.92
Apr 21 12.40 12.17 12.64 3.84
Apr 22 12.52 12.38 12.71 2.66
Apr 23 12.71 12.52 12.91 3.12

BridgeBio Pharma Daily Price Targets


BridgeBio Pharma Stock Forecast 03-25-2023.

Forecast target price for 03-25-2023: $12.88.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 4.456%.
Pessimistic target level: 12.67
Optimistic target level: 13.26

BridgeBio Pharma Stock Forecast 03-26-2023.

Forecast target price for 03-26-2023: $12.76.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 4.182%.
Pessimistic target level: 12.44
Optimistic target level: 12.98

BridgeBio Pharma Stock Forecast 03-27-2023.

Forecast target price for 03-27-2023: $12.45.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 4.014%.
Pessimistic target level: 12.12
Optimistic target level: 12.63

BridgeBio Pharma Stock Forecast 03-28-2023.

Forecast target price for 03-28-2023: $12.32.
Negative dynamics for BridgeBio Pharma shares will prevail with possible volatility of 4.227%.
Pessimistic target level: 12.08
Optimistic target level: 12.61

BridgeBio Pharma Stock Forecast 03-29-2023.

Forecast target price for 03-29-2023: $12.65.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 4.320%.
Pessimistic target level: 12.44
Optimistic target level: 13.00

BridgeBio Pharma Stock Forecast 03-30-2023.

Forecast target price for 03-30-2023: $13.09.
Positive dynamics for BridgeBio Pharma shares will prevail with possible volatility of 4.806%.
Pessimistic target level: 12.76
Optimistic target level: 13.40

BBIO (BBIO) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Apr. 13.42 13.03 14.10 7.55
May. 12.60 11.48 13.20 13.02
Jun. 12.79 12.11 14.04 13.74
Jul. 12.43 11.17 13.67 18.32
Aug. 12.48 12.14 13.50 10.09
Sep. 12.09 11.71 12.57 6.87
Oct. 12.92 11.95 13.42 11.01
Nov. 12.74 11.54 13.51 14.58
Dec. 12.75 12.32 13.88 11.23

BridgeBio Pharma forecast for this year


BridgeBio Pharma Stock Prediction for Apr 2023

An uptrend is forecast for this month with an optimal target price of $13.4176. Pessimistic: $13.03. Optimistic: $14.10


BridgeBio Pharma Stock Prediction for May 2023

An downtrend is forecast for this month with an optimal target price of $12.5978. Pessimistic: $11.48. Optimistic: $13.20


BridgeBio Pharma Stock Prediction for Jun 2023

An uptrend is forecast for this month with an optimal target price of $12.7943. Pessimistic: $12.11. Optimistic: $14.04


BridgeBio Pharma Stock Prediction for Jul 2023

An downtrend is forecast for this month with an optimal target price of $12.4284. Pessimistic: $11.17. Optimistic: $13.67


BridgeBio Pharma Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $12.4769. Pessimistic: $12.14. Optimistic: $13.50


BridgeBio Pharma Stock Prediction for Sep 2023

An downtrend is forecast for this month with an optimal target price of $12.0876. Pessimistic: $11.71. Optimistic: $12.57


BridgeBio Pharma Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $12.9204. Pessimistic: $11.95. Optimistic: $13.42


BridgeBio Pharma Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $12.7357. Pessimistic: $11.54. Optimistic: $13.51


BridgeBio Pharma Stock Prediction for Dec 2023

An uptrend is forecast for this month with an optimal target price of $12.7522. Pessimistic: $12.32. Optimistic: $13.88



BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 12.22 11.79 12.90 8.62
Feb 11.41 10.28 12.11 15.07
Mar 11.90 11.44 12.97 11.81
Apr 11.16 10.27 11.46 10.38
May 11.81 11.27 12.16 7.32
Jun 12.66 12.18 13.28 8.30
Jul 12.36 11.28 12.73 11.36
Aug 12.70 11.84 13.85 14.54
Sep 13.47 13.12 14.87 11.78
Oct 13.51 12.51 14.28 12.42
Nov 13.68 12.46 14.55 14.42
Dec 13.68 12.76 14.11 9.58

BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 13.59 12.20 14.34 14.92
Feb 13.49 12.47 13.87 10.11
Mar 13.42 12.25 13.99 12.46
Apr 13.10 12.53 13.67 8.35
May 14.55 13.19 14.99 11.99
Jun 15.38 14.38 16.34 11.99
Jul 14.48 13.64 15.92 14.32
Aug 14.15 13.47 14.64 8.04
Sep 13.76 12.36 14.65 15.62
Oct 13.94 13.38 14.72 9.11
Nov 14.92 14.12 16.31 13.43
Dec 15.75 15.01 16.45 8.71

BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 17.49 15.74 18.67 15.71
Feb 17.35 16.20 18.12 10.58
Mar 16.66 15.07 18.19 17.14
Apr 17.39 15.81 18.79 15.88
May 18.84 17.10 19.79 13.61
Jun 19.03 17.33 19.65 11.84
Jul 17.67 16.04 18.66 14.04
Aug 16.59 15.84 17.84 11.24
Sep 17.35 16.67 17.93 7.04
Oct 17.66 16.59 18.74 11.52
Nov 16.84 16.25 18.35 11.45
Dec 18.02 16.80 18.56 9.47

BridgeBio Pharma (BBIO) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 18.72 18.19 20.33 10.54
Feb 17.89 17.31 19.29 10.25
Mar 19.27 17.29 20.87 17.16
Apr 20.44 18.98 21.75 12.71
May 20.58 18.60 21.14 12.02
Jun 20.18 18.21 21.07 13.57
Jul 20.99 19.90 21.54 7.60
Aug 20.03 18.00 21.68 16.94
Sep 18.05 16.93 18.88 10.32
Oct 18.05 17.14 19.35 11.40
Nov 18.03 17.02 19.74 13.77
Dec 18.22 17.01 18.88 9.91

BridgeBio Pharma information and performance

BridgeBio Pharma, Inc. is engaged in the discovery, development and supply of various drugs for genetic diseases. The company has a portfolio of 20 development programs that include candidate products from early discovery to late development.

BridgeBio Pharma Address

421 KIPLING STREET, PALO ALTO, CA, US

Market Capitalization: 2 209 057 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -461 665 984 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -3.2

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.855
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 28.78

Enterprise Value (EV) /Revenue

EV To EBITDA: -6.16

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 160197000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.